Clinical Trials for Arbutus Biopharma

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Arbutus Biopharma

Clinical Trials (3)

NCT06154278
Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
PHASE2Recruiting
10 participants
Started: Jul 25, 2024 · Completed: Jul 1, 2027
1 condition2 sponsors1 location
NCT06277037
Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
N/ARecruiting
50 participants
Started: Jul 11, 2024 · Completed: Oct 30, 2029
1 condition1 sponsor18 locations
NCT05960240
Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.
PHASE1Active, not recruiting
128 participants
Started: Aug 30, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor10 locations